Trials / Completed
CompletedNCT00512785
Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder
An Open-label Study to Evaluate the Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 435 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the long-term safety and efficacy of imidafenacin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | imidafenacin, KRP-197/ONO-8025 | 0.1 mg BID for 52 weeks |
| DRUG | imidafenacin, KRP-197/ONO-8025 | 0.1 mg BID for 12 weeks and 0.2 mg BID for 52 weeks |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2009-05-01
- First posted
- 2007-08-08
- Last updated
- 2012-06-13
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00512785. Inclusion in this directory is not an endorsement.